A series of 17 new substituted amides and hydrazides of N-acyl-5-bromanthranilic acids were synthesized. The antimicrobial activity of these compounds with respect to St. aureus and E. coli was evaluated. It was found that of N-chloracetyl-5-bromanthranlic acid methylamide and hydrazide significantly suppressed the growth of test microbes, with a minimum inhibitory concentration of 15.6 mg/ml against St. aureus and 15.6 -31.5 mg/ml against E. coli. The other tested compounds were significantly less active. 483 0091-150X/07/4109-0483
Acylation of 5-bromo(3,5-dibromo)anthranilic acids with the corresponding anhydrides yielded 10 N-acyl-5-bromo(3,5-dibromo)anthranilic acids. The resulting compounds were reacted with 10% sodium hydroxide to convert them to the corresponding sodium salts. The hemostatic and antimicrobial activities against Staphylococcus aureus and Escherichia coli of the resulting compounds were studied. Compound IV, containing a phenyl residue in the acyl fragment, was found to have marked hemostatic activity (18.2%) and weak antimicrobial activity. The minimum inhibitory concentration for this compound was 500 mg/ml against S. aureus and E. coli. The other sodium salts were significantly less active.Key words: Sodium salts of N-acyl-5-bromo(3,5-dibromo)anthranilic acids, hemostatic and antimicrobial activities, synthesis.Anthranilic acid is known to take part in the biosynthesis of antibiotics [1], while the sodium salts of N-acylanthranilic acids have anti-inflammatory, antiproteolytic, and antimicrobial activities [2,3].We report here the synthesis of the sodium salts of N-acyl-5-bromo(3,5-dibromo)anthranilic acids [4] and studies of their hemostatic and antimicrobial actions.N-acyl-5-bromo(3,5-dibromo)anthranilic acids (I -IV, VI -X) were synthesized by acylation of 5-bromo-(3,5-dibromo)anthranilic acids with monocarboxylic acid anhydrides. Compound V was prepared by reaction with phthalic anhydride in ethyl acetate using a published method [5]; derivatives I and VIII were prepared in glacial acetic acid at room temperature; compound II was obtained in pyridine at 18°C. The calculated quantities of 10% NaOH were used to convert the compounds into their sodium salts; in the case of compound V, the disodium salt of N-phthalyl-5-bromoanthranilic acid was obtained.The sodium salts of compounds I -X were crystalline substances, white or white with a yellow tinge, soluble in water, ethanol, DMSO, and DMF. Structures were confirmed using their IR and 1 H NMR spectra (Table 1).
EXPERIMENTAL CHEMICAL SECTIONThe 1 H NMR spectra of compounds I -X were recorded on a BS-567A spectrometer (working frequency 100 MHz) in DMSO-d 6 with HMDS as the internal standard; 1 H NMR spectra are given in Table 1. IR spectra were taken on a Specord M-80 spectrophotometer in Vaseline grease. Reaction courses and compound purities were monitored by TLC on Silufol UV-254 ® plates developed in acetone:chloroform (1:9); spots were detected with iodine vapor. The physicochemical properties of study compounds are shown in Table 1. Elemental analysis data for the compounds synthesized here were consistent with calculated values.N-Phthalyl-5-bromoanthranilic acid (V). A solution of 2.22 g (15 mmol) of phthalic anhydride in 10 ml of ethyl acetate was poured into a solution of 3.2 g (15 mmol) of 5-bromoanthranilic acid in 10 ml of ethyl acetate with mixing. The reaction mixture was kept for 24 h. The resulting precipitate was collected by filtration, dried, and recrystallized from a mixture of water and ethanol (2:1). The 12 0091-150X/11/4501-0012
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.